IP vs LCTX
International Paper (IP) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the IP and LCTX stock pages for the full models.
Not investment advice.